The Bereitschaftspotential, L-DOPA and Parkinson's disease

Area of Science:

• Neuroscience
• Motor Control
• Neuropharmacology

Background:

• Bereitschaftspotentials (BPs) are electrophysiological signals preceding voluntary movements.
• Parkinson's disease (PD) is a neurodegenerative disorder affecting motor control, often treated with L-DOPA.
• The precise role of dopaminergic pathways in BP generation remains under investigation.

Purpose of the Study:

• To investigate the effects of L-DOPA and dopaminergic antagonists on Bereitschaftspotentials (BPs) in normal subjects and Parkinson's disease (PD) patients.
• To determine if L-DOPA therapy alters the amplitude and characteristics of BPs in PD.
• To explore the potential involvement of dopaminergic mechanisms in the generation of specific BP components.

Main Methods:

• Recorded BPs during index finger extension movements in healthy controls and PD patients.
• Administered L-DOPA to both groups and dopamine antagonists to controls.
• Analyzed BP amplitude, particularly the early component (N1) and the late lateralized component (NS').

Main Results:

• L-DOPA increased the amplitude of the early BP component (N1) in both PD patients and normal subjects.
• L-DOPA did not affect the late lateralized component (NS') of the BP.
• Dopamine antagonists decreased the N1 amplitude in normal subjects.
• No correlation was found between L-DOPA's effect on N1 and clinical mobility improvement in PD patients.
• PD patients OFF therapy showed no difference in N1 peak negativity compared to age-matched controls, but had a slight decrease in early BP amplitude.

Conclusions:

• The early BP component (N1) appears unaffected by Parkinson's disease itself.
• Dopaminergic drugs likely influence N1 via mechanisms outside the striatum, possibly in the cerebral cortex.
• L-DOPA's effects on BP must be considered in future research on Parkinson's disease.